Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis.

MLA

Carrasco-Campos, María Isabel, et al. “Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis.” Molecular Neurobiology, vol. 58, no. 9, Sept. 2021, pp. 4716–26. EBSCOhost, https://doi.org/10.1007/s12035-021-02454-2.

APA

Carrasco-Campos, M. I., Pérez-Ramírez, C., Macías-Cortés, E., Puerta-García, E., Sánchez-Pozo, A., Arnal-García, C., Barrero-Hernández, F. J., Calleja-Hernández, M. Á., Jiménez-Morales, A., & Cañadas-Garre, M. (2021). Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis. Molecular Neurobiology, 58(9), 4716–4726. https://doi.org/10.1007/s12035-021-02454-2

Chicago

Carrasco-Campos, María Isabel, Cristina Pérez-Ramírez, Elena Macías-Cortés, Elena Puerta-García, Antonio Sánchez-Pozo, Carmen Arnal-García, Francisco Javier Barrero-Hernández, Miguel Ángel Calleja-Hernández, Alberto Jiménez-Morales, and Marisa Cañadas-Garre. 2021. “Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis.” Molecular Neurobiology 58 (9): 4716–26. doi:10.1007/s12035-021-02454-2.